16:30 EST Contineum (CTNM) Therapeutics Inc trading resumes
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTNM:
- Contineum Phase 2 VISTA trial did not meet primary, secondary endpoints
- Contineum Therapeutics Inc trading halted, news pending
- Buy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities
- Contineum Therapeutics Reports Increased R&D Investment Amid Losses
- Contineum reports Q3 EPS (45c), consensus (46c)